Status:
COMPLETED
The Screening and Analysis of Plasma Biomarkers in Irreversible PAH-CHD
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Hypertension,Pulmonary
Eligibility:
All Genders
1-18 years
Brief Summary
The purpose of this study is to analyse the sensitivity and specificity of circulating endothelial cells to predict irreversible pulmonary arterial hypertension associated with congenital heart diseas...
Detailed Description
predict to recruit 100 patients with pulmonary arterial hypertension (PAH)associated with CHD，under the commitment of the children's parents，take 3-4ml central venous blood before the corrective surge...
Eligibility Criteria
Inclusion
- Only those patients with systolic PAP (sPAP) \>65mmHg before surgery were included.
Exclusion
- Patients with trisomy 21 (Down syndrome) were not included
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2016
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT02267200
Start Date
October 1 2014
End Date
September 1 2016
Last Update
November 22 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Children's Medical Center
Shanghai, Shanghai Municipality, China, 200127